Selected article for: "cohort study and retrospective cohort study"
Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
    • ID: ri2w5iby_113
    Snippet: This retrospective, open label, cohort study evaluated IW receiving pimobendan (n = 25; 0.24-0.26 mg/kg PO q12 h); benazepril (n = 24; 0.25-0.5 mg/kg PO q 12 h); methyldigoxin (n = 21; 0.005 mg/kg PO q 12 h); methyldigoxin+benazepril (n = 40); or pimobendan+benazepril (n = 11), for up to 7.8 years. Time to events were estimated by Kaplan Meier method for first onset of CHF, cardiac death, and all-cause mortality using pair-wise comparisons betwee.....
    Document: This retrospective, open label, cohort study evaluated IW receiving pimobendan (n = 25; 0.24-0.26 mg/kg PO q12 h); benazepril (n = 24; 0.25-0.5 mg/kg PO q 12 h); methyldigoxin (n = 21; 0.005 mg/kg PO q 12 h); methyldigoxin+benazepril (n = 40); or pimobendan+benazepril (n = 11), for up to 7.8 years. Time to events were estimated by Kaplan Meier method for first onset of CHF, cardiac death, and all-cause mortality using pair-wise comparisons between groups. Pooled data from 86 IW with echocardiographic follow-up were dichotomized based upon improvement in %FS, LV end-systolic, and LV end-diastolic dimensions into references ranges ('responders'), vs. no echo improvement ('nonresponders'), to compare cardiac survival.

    Search related documents:
    Co phrase search for related documents
    • cardiac death and cause mortality cardiac death: 1, 2, 3, 4, 5
    • cardiac death and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cardiac death and end diastolic: 1
    • cardiac death and event time: 1, 2, 3, 4
    • cardiac death and Kaplan Meier method: 1, 2, 3
    • cardiac survival and cause mortality: 1, 2, 3, 4, 5, 6
    • cardiac survival and cohort study: 1, 2, 3, 4, 5, 6, 7, 8
    • cardiac survival and event time: 1
    • cause mortality and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cause mortality and end diastolic: 1, 2, 3
    • cause mortality and end systolic: 1
    • cause mortality and event time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cause mortality and Kaplan Meier method: 1, 2, 3, 4, 5, 6, 7
    • cause mortality and LV end systolic: 1
    • cause mortality and open label: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cause mortality cardiac death and cohort study: 1
    • cohort study and end diastolic: 1, 2, 3, 4, 5, 6
    • cohort study and end systolic: 1, 2, 3
    • cohort study and event time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25